RZRosemary Zvonar

Rosemary Zvonar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rosemary Zvonar has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Comparison of Vancomycin Area Under the Curve and Trough Concentration in Specific Populations

    by Kadaajah L T Johnson-Louis, My-Linh Nguyen, Rosemary K Zvonar

    Background: Vancomycin is an antibiotic known to cause nephrotoxicity, particularly when a vancomycin trough of 15 to 20 mg/L, a surrogate for an area under the curve (AUC) of at least 400 mgh/L, is targeted. Although monitoring vancomycin AUC is more resource intensive, it may especially benefit populations expected to be at higher risk of nephrotoxicity. Objective: To describe the proportion of discordance between vancomycin AUC and trough concentration in targeted high-risk populations. Methods: A prospective observational review was conducted on adults receiving intravenous vancomycin for more than 48 hours from May 9 to June 3, 2022. Patients included were elderly, obese, had renal dysfunction, and/or received 4 grams or more of vancomycin daily with a pending vancomycin trough concentration. A peak concentration was ordered by a project team member to calculate AUC to assess discordance. Results: A total of 47 patients were included with 87 vancomycin minimum concentration (Cmin)/AUC pairs analyzed. Discordance was observed in 52.9% of Cmin/AUC pairs in the entire cohort. The majority (79%) of the 43 Cmin levels 400 mgh/L and 57% of 21 Cmin levels within the 15 to 20 mg/L range had an AUC >600 mgh/L. Conclusion: A high degree of discordance between vancomycin Cmin and AUC was present in patients considered to be at high risk of nephrotoxicity. Monitoring vancomycin AUC in these patients may reduce the risk of nephrotoxicity.


  • Open Access

    A recipe for antimicrobial stewardship success: Using intervention mapping to develop a program to reduce antibiotic overuse in long-term care

    by Andrea Chambers, Sam MacFarlane, Rosemary Zvonar, Gerald Evans, Julia E. Moore, Bradley J. Langford, Anne Augustin, Sue Cooper, Jacquelyn Quirk, Liz McCreight, et al.

    Objective: To better understand barriers and facilitators that contribute to antibiotic overuse in long-term care and to use this information to inform an evidence and theory-informed program.Methods: Information on barriers and facilitators associated with the assessment and management of urinary tract infections were identified from a mixed-methods survey and from focus groups with stakeholders working in long-term care. Each barrier or facilitator was mapped to corresponding determinants of behavior change, as described by the theoretical domains framework (TDF). The Rx for Change database was used to identify strategies to address the key determinants of behavior change.Results: In total, 19 distinct barriers and facilitators were mapped to 8 domains from the TDF: knowledge, skills, environmental context and resources, professional role or identity, beliefs about consequences, social influences, emotions, and reinforcements. The assessment of barriers and facilitators informed the need for a multifaceted approach with the inclusion of strategies (1) to establish buy-in for the changes; (2) to align organizational policies and procedures; (3) to provide education and ongoing coaching support to staff; (4) to provide information and education to residents and families; (5) to establish process surveillance with feedback to staff; and (6) to deliver reminders.Conclusions: The use of a stepped approach was valuable to ensure that locally relevant barriers and facilitators to practice change were addressed in the development of a regional program to help long-term care facilities minimize antibiotic prescribing for asymptomatic bacteriuria. This stepped approach provides considerable opportunity to advance the design and impact of antimicrobial stewardship programs.


  • Open Access

    Evaluating Antimicrobial Use and Spectrum of Activity in Ontario Hospitals: Feasibility of a Multicentered Point Prevalence Study

    by Valerie Leung, Michael Li, Julie Hui-Chih Wu, Bradley Langford, Rosemary Zvonar, Jeff Powis, Julie Longpre, Lizanne Béïque, Suzanne Gill, Grace Ho, et al.

    Background: Antimicrobial stewardship, a key component of an overall strategy to address antimicrobial resistance, has been recognized as a global priority. The ability to track and benchmark antimicrobial use (AMU) is critical to advancing stewardship from an organizational and provincial perspective. As there are few comprehensive systems in Canada that allow for benchmarking, Public Health Ontario conducted a pilot in 2016/2017 to assess the feasibility of using a point prevalence methodology as the basis of a province-wide AMU surveillance program. Methods: Three acute care hospitals of differing sizes in Ontario, Canada, participated. Adults admitted to inpatient acute care beds on the survey date were eligible for inclusion; a sample size of 170 per hospital was targeted, and data were collected for the 24-hour period before and including the survey date. Debrief sessions at each site were used to gather feedback about the process. Prevalence of AMU and the Antimicrobial Spectrum Index (ASI) was reported for each hospital and by indication per patient case. Results: Participants identified required improvements for scalability including streamlining ethics, data sharing processes, and enhancing the ability to compare with peer organizations at a provincial level. Of 457 patients, 172 (38%) were receiving at least 1 antimicrobial agent. Beta-lactam/beta-lactamase inhibitors were the most common (18%). The overall mean ASI per patient was 6.59; most cases were for treatment of infection (84%). Conclusions: This pilot identified factors and features required for a scalable provincial AMU surveillance program; future efforts should harmonize administrative processes and enable interfacility benchmarking.


  • Open Access

    Potential Negative Effects of Antimicrobial Allergy Labelling on Patient Care: A Systematic Review

    by Julie Hui-Chih Wu, Bradley J Langford, Kevin L Schwartz, Rosemary Zvonar, Sumit Raybardhan, Valerie Leung, Gary Garber

    Background: Antimicrobial allergy labels, either self-reported or placed in a patient’s medical record, are common, but in many cases they are not associated with a true immunoglobulin E–mediated allergic response.Objective: To assess the impact of antimicrobial allergy labels on anti - microbial prescribing, resource utilization, and clinical outcomes.Data Sources: The MEDLINE, Embase, CINAHL, and Scopus electronic databases were searched for the period 1990 to January 2016.Study Selection: Controlled studies with the objective of assessing antimicrobial prescribing, resource utilization, and/or clinical outcomes associated with antimicrobial allergy labels were included.Results: The search identified 560 unique citations, of which 7 articles met the inclusion criteria. One additional article identified by an expert in the field was also included. Four of the identified papers were limited to penicillin or other ß-lactam allergies. Six studies noted differences in antibiotic selection between patients with allergy labels and those without such labels. Broader-spectrum or second-line agents (e.g., vancomycin, clindamycin, and fluoroquinolones) were more commonly prescribed for patients with penicillin allergy labels. Antibiotic therapy costs were significantly higher for patients with allergy labels than for those without. The impact of allergy labels on clinical outcomes was mixed. One study indicated a longer length of hospital stay, 2 studies reported higher readmission rates, and 1 study reported a higher rate of antibiotic-resistant organisms for patients with allergy labels.Conclusions: Most of the available literature is limited to penicillin or ß-lactam allergy. The growing body of knowledge supports the concept that ß-lactam allergy labels are not benign and that labelling in the absence of a true allergy has a negative effect on patient care. Allergy labelling appears to be associated with suboptimal antibiotic selection, greater treatment costs, prolonged length of stay, greater readmission rates, and higher prevalence of antibiotic-resistant organisms. There is an opportunity for antimicrobial stewardship programs to implement systematic allergy verification to optimize antimicrobial therapy and improve patient care. RÉSUMÉContexte: Les mentions d’allergies aux antimicrobiens, soit autodéclarées soit consignées dans un dossier médical, sont fréquentes, mais dans bien des cas elles ne signalent pas une véritable réaction allergique à mediation par l’immunoglobuline E.Objectif : Évaluer l’effet des mentions d’allergie aux antimicrobiens sur les habitudes de prescription d’antimicrobiens, l’utilisation des ressources et les résultats cliniques.Sources des données : Les bases de données numériques MEDLINE, Embase, CINAHL et Scopus ont été interrogées pour la période allant de 1990 à janvier 2016.Sélection des études : Les essais cliniques comparatifs dont l’objectif était d’évaluer les habitudes de prescription d’antimicrobiens, l’utilisation des ressources ou les résultats cliniques associés aux mentions d’allergie aux antimicrobiens ont été inclus.Résultats : La recherche a permis de trouver 560 citations distinctes et ainsi de repérer sept articles qui répondaient aux critères d’inclusion. Un article supplémentaire signalé par un expert du domaine a été inclus à l’analyse. Quatre de ces articles se limitaient aux allergies à la pénicilline ou à d’autres ß-lactamines. Six études ont noté des différences dans le choix des antibiotiques entre les patients ayant une mention d’allergie à leur dossier et ceux n’en ayant pas. Des antibiotiques à plus large spectre ou des médicaments de deuxième intention (comme la vancomycine, la clindamycine et les fluoroquinolones) étaient plus souvent prescrits pour les patients ayant une mention d’allergie à la pénicilline. Les coûts des antibiothérapies étaient significativement plus élevés pour les patients ayant une mention d’allergie que pour ceux n’en ayant pas à leur dossier. L’effet des mentions d’allergie sur les résultats cliniques était inégal. Une étude indiquait un séjour plus long à l’hôpital, deux études indiquaient des taux de réadmission plus élevés et une étude indiquait un taux plus élevé d’organismes résistants aux antibiotiques pour les patients ayant une mention d’allergie comparativement à ceux n’en ayant pas.Conclusions : La majeure partie des articles disponibles se limitent aux allergies à la pénicilline ou à d’autres ß-lactamines. De plus en plus, le savoir vient appuyer le concept voulant que les mentions d’allergies aux ß-lactamines ne soient pas bénignes et que leur emploi en l’absence d’une allergie réelle ait un effet négatif sur les soins aux patients. Les mentions d’allergie semblent être associées à un choix sous-optimal d’antibiotiques, des coûts de traitement plus élevés, des séjours plus longs, des taux de réadmission plus élevés et une plus grande prévalence d’organismes résistants aux antibiotiques. Or, les programmes de gérance des antimicrobiens pourraient permettre de mettre en oeuvre des procédures de verification systématique des allergies afin d’optimiser l’antibiothérapie et d’améliorer les soins aux patients.


  • Open Access

    Should Prolonged Infusion of ß-Lactams Become Standard of Practice?

    by Reem Haj-Darrah, Elizabeth Leung, Rosemary Zvonar

    Should Prolonged Infusion of ß-Lactams Become Standard of Practice?


  • Open Access

    Variability in antibiotic use across Ontario acute care hospitals

    by Charlie Tan, Marian Vermeulen, Xuesong Wang, Rosemary Zvonar, Gary Garber, Nick Daneman

    Background: Antibiotic stewardship is a required organizational practice for Canadian acute care hospitals, yet data are scarce regarding the quantity and composition of antibiotic use across facilities. We sought to examine the variability, and risk-adjusted variability, in antibiotic use across acute care hospitals in Ontario, Canada’s most populous province. Methods: Antibiotic purchasing data from IMS Health, previously demonstrated to correlate strongly with internal antibiotic dispensing data, were acquired for 129 Ontario hospitals from January to December 2014 and linked to patient day (PD) denominator data from administrative datasets. Hospital variation in DDDs/1000 PDs was determined for overall antibiotic use, class-specific use and six practices of clinical or ecological significance. Multivariable risk adjustment for hospital and patient characteristics was used to compare observed versus expected utilization. Results: There was 7.4-fold variability in the quantity of antibiotic use across the 129 acute care hospitals, from 253 to 1873 DDDs/1000 PDs. Variation was evident within hospital subtypes, exceeded that explained by hospital and patient characteristics, and included wide variability in proportion of broad-spectrum antibiotics (IQR 36%–48%), proportion of fluoroquinolones among respiratory antibiotics (IQR 40%–62%), proportion of ciprofloxacin among urinary anti-infectives (IQR 44%–60%), proportion of antibiotics with highest risk for Clostridium difficile (IQR 29%–40%), proportion of ‘reserved-use’ antibiotics (IQR 0.8%–3.5%) and proportion of anti-pseudomonal antibiotics among antibiotics with Gram-negative coverage (IQR 26%–40%). Conclusions: There is extensive variability in antibiotic use, and risk-adjusted use, across acute care hospitals. This could motivate, focus and benchmark antibiotic stewardship efforts.


  • Open Access

    Comparison of Metronidazole q12h to q8h in Combination With Other Antibiotics on the Clinical Outcome and Readmission Rate of Patients With Appendicitis and Diverticulitis

    by Lizanne Béïque, Corey Tsang, Stephanie Geertsema, Rosemary Zvonar, Caroline Nott, Janet Squires, Kathryn Suh

    Background. Pharmacokinetic, pharmacodynamic and limited published clinical data support the administration of metronidazole in a twice daily (q12h) regimen versus three times daily (q8h). As part of an Antimicrobial Stewardship initiative, we started promoting this change in practice in March 2015 during weekly rounds with the General Surgery team. The objectives of this study are to determine if metronidazole 500 mg q12h differs from q8h in patients with appendicitis or diverticulitis, regarding 30-day clinical outcomes and readmission rates.

  • Open Access

    Impact of a Pathway for Chronic Obstructive Pulmonary Disease Exacerbations (COPDE) on Antimicrobial Prescribing and Readmissions

    by Lizanne Béïque, Rosemary Zvonar, Virginia Roth, Stephanie Bui, Adam Ling, Kathryn Suh

    Background. Chronic obstructive pulmonary disease exacerbations (COPDE) are frequently overtreated with antibiotics. In April 2014, a clinical pathway for COPDE was released as part of our Antimicrobial Stewardship Program (ASP) at The Ottawa Hospital (TOH). TOH is an 1100-bed, tertiary-care institution in Ottawa, Canada, with acute care beds distributed over two geographically distinct campuses.

  • Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients

    by Lizanne Béïque, Rosemary Zvonar

    Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients


  • Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase– Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital

    by My-Linh Nguyen, Baldwin Toye, Salmaan Kanji, Rosemary Zvonar

    Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase– Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital